BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26948691)

  • 1. Tocotrienol and cancer metastasis.
    De Silva L; Chuah LH; Meganathan P; Fu JY
    Biofactors; 2016; 42(2):149-62. PubMed ID: 26948691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.
    Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocotrienol as a potential anticancer agent.
    Ling MT; Luk SU; Al-Ejeh F; Khanna KK
    Carcinogenesis; 2012 Feb; 33(2):233-9. PubMed ID: 22095072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol).
    Miyazawa T; Shibata A; Sookwong P; Kawakami Y; Eitsuka T; Asai A; Oikawa S; Nakagawa K
    J Nutr Biochem; 2009 Feb; 20(2):79-86. PubMed ID: 19071006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK; Sanders BG; Kline K
    Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells.
    Liu HK; Wang Q; Li Y; Sun WG; Liu JR; Yang YM; Xu WL; Sun XR; Chen BQ
    J Nutr Biochem; 2010 Mar; 21(3):206-13. PubMed ID: 19195866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent.
    Yano T; Sato A; Sekine M; Virgona N; Ota M
    Anticancer Agents Med Chem; 2013 Mar; 13(3):496-501. PubMed ID: 22721395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.
    Shin-Kang S; Ramsauer VP; Lightner J; Chakraborty K; Stone W; Campbell S; Reddy SA; Krishnan K
    Free Radic Biol Med; 2011 Sep; 51(6):1164-74. PubMed ID: 21723941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of tocotrienols in the treatment and prevention of breast cancer.
    Sylvester PW; Akl MR; Malaviya A; Parajuli P; Ananthula S; Tiwari RV; Ayoub NM
    Biofactors; 2014; 40(1):49-58. PubMed ID: 23804535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.
    Aggarwal BB; Sundaram C; Prasad S; Kannappan R
    Biochem Pharmacol; 2010 Dec; 80(11):1613-31. PubMed ID: 20696139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
    Eitsuka T; Tatewaki N; Nishida H; Nakagawa K; Miyazawa T
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitargeted therapy of cancer by tocotrienols.
    Nesaretnam K
    Cancer Lett; 2008 Oct; 269(2):388-95. PubMed ID: 18504069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural forms of vitamin E and metabolites-regulation of cancer cell death and underlying mechanisms.
    Jiang Q
    IUBMB Life; 2019 Apr; 71(4):495-506. PubMed ID: 30548200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. δ-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy.
    Shibata A; Nakagawa K; Tsuduki T; Miyazawa T
    J Nutr Biochem; 2015 Aug; 26(8):832-40. PubMed ID: 25979648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols.
    Constantinou C; Charalambous C; Kanakis D
    Eur J Nutr; 2020 Apr; 59(3):845-857. PubMed ID: 31016386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocotrienol research: past into present.
    Wong RS; Radhakrishnan AK
    Nutr Rev; 2012 Sep; 70(9):483-90. PubMed ID: 22946849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets.
    Montagnani Marelli M; Marzagalli M; Fontana F; Raimondi M; Moretti RM; Limonta P
    J Cell Physiol; 2019 Feb; 234(2):1147-1164. PubMed ID: 30066964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents.
    Fontana F; Raimondi M; Marzagalli M; Moretti RM; Marelli MM; Limonta P
    Recent Pat Anticancer Drug Discov; 2019; 14(1):5-18. PubMed ID: 30652648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of tocotrienols: the mechanism of antiproliferative effects.
    Wada S
    Forum Nutr; 2009; 61():204-216. PubMed ID: 19367124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.